Pnc Financial Services Group, Inc. Rocket Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 20,664 shares of RCKT stock, worth $57,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,664

Previous 22,455 7.98%

Holding current value

$57,239

Previous $282,000 51.42%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$6.67 - $12.72 $11,945 - $22,781	-1,791 Reduced 7.98%	20,664 $137,000
Q4 2024 Feb 07, 2025	BUY	$11.35 - $18.82 $71,981 - $119,356	6,342 Added 39.36%	22,455 $282,000
Q3 2024 Nov 08, 2024	BUY	$17.6 - $25.88 $10,155 - $14,932	577 Added 3.71%	16,113 $297,000
Q2 2024 Aug 09, 2024	BUY	$20.66 - $26.72 $15,866 - $20,520	768 Added 5.2%	15,536 $334,000
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $15,251 - $17,921	-583 Reduced 3.8%	14,768 $397,000
Q4 2023 Feb 09, 2024	SELL	$16.78 - $31.94 $25,086 - $47,750	-1,495 Reduced 8.87%	15,351 $460,000
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $30,350 - $48,436	2,014 Added 13.58%	16,846 $345,000
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $7,963 - $11,328	480 Added 3.34%	14,832 $294,000
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $1,405 - $2,011	89 Added 0.62%	14,352 $245,000
Q4 2022 Feb 10, 2023	BUY	$15.5 - $22.76 $30,302 - $44,495	1,955 Added 15.88%	14,263 $279,000
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $8,127 - $12,095	657 Added 5.64%	12,308 $196,000
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $26,984 - $56,409	3,390 Added 41.04%	11,651 $160,000
Q1 2022 May 12, 2022	SELL	$13.16 - $23.68 $381 - $686	-29 Reduced 0.35%	8,261 $131,000
Q4 2021 Feb 11, 2022	SELL	$21.52 - $36.02 $7,467 - $12,498	-347 Reduced 4.02%	8,290 $180,000
Q3 2021 Nov 05, 2021	BUY	$27.42 - $48.97 $9,322 - $16,649	340 Added 4.1%	8,637 $258,000
Q2 2021 Aug 06, 2021	BUY	$39.41 - $47.25 $25,655 - $30,759	651 Added 8.51%	8,297 $367,000
Q1 2021 May 07, 2021	SELL	$43.34 - $65.91 $39,222 - $59,648	-905 Reduced 10.58%	7,646 $339,000
Q4 2020 Feb 12, 2021	SELL	$23.3 - $59.57 $9,995 - $25,555	-429 Reduced 4.78%	8,551 $468,000
Q2 2020 Aug 07, 2020	SELL	$13.32 - $22.61 $8,258 - $14,018	-620 Reduced 6.46%	8,980 $187,000
Q1 2020 May 08, 2020	BUY	$9.71 - $25.11 $93,216 - $241,056	9,600 New	9,600 $133,000

Others Institutions Holding RCKT

# of Institutions

258

Shares Held

108M

Call Options Held

555K

Put Options Held

177K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $210M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Rocket Pharmaceuticals, Inc. Transaction History